| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Dapagliflozin as monotherapy or combination therapy in Japanese patients with type 2 diabetes: an open-label study. | Diabetes Ther | 2014 | 1.08 |
| 2 | Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer. | Invest New Drugs | 2015 | 0.88 |
| 3 | Phase I clinical and pharmacokinetic study of 3-weekly, 3-h infusion of ixabepilone (BMS-247550), an epothilone B analog, in Japanese patients with refractory solid tumors. | Cancer Chemother Pharmacol | 2007 | 0.86 |
| 4 | Efficacy and safety of ixabepilone in taxane-resistant patients with metastatic breast cancer previously treated with anthracyclines: results of a phase II study in Japan. | Cancer Chemother Pharmacol | 2013 | 0.76 |